Sharing an AI brain between bio labs. Fighting quantum errors. The data center backlash. There’s all that and more in this week’s Prototype. ByAlex Knapp,Senior Editor
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
First reported:
First saved on ClustZ:
Coverage updated:
We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.